Literature DB >> 28634160

High-Throughput Characterization of Cascade type I-E CRISPR Guide Efficacy Reveals Unexpected PAM Diversity and Target Sequence Preferences.

Becky Xu Hua Fu1, Michael Wainberg2, Anshul Kundaje1,2, Andrew Z Fire1,3.   

Abstract

Interactions between Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) RNAs and CRISPR-associated (Cas) proteins form an RNA-guided adaptive immune system in prokaryotes. The adaptive immune system utilizes segments of the genetic material of invasive foreign elements in the CRISPR locus. The loci are transcribed and processed to produce small CRISPR RNAs (crRNAs), with degradation of invading genetic material directed by a combination of complementarity between RNA and DNA and in some cases recognition of adjacent motifs called PAMs (Protospacer Adjacent Motifs). Here we describe a general, high-throughput procedure to test the efficacy of thousands of targets, applying this to the Escherichia coli type I-E Cascade (CRISPR-associated complex for antiviral defense) system. These studies were followed with reciprocal experiments in which the consequence of CRISPR activity was survival in the presence of a lytic phage. From the combined analysis of the Cascade system, we found that (i) type I-E Cascade PAM recognition is more expansive than previously reported, with at least 22 distinct PAMs, with many of the noncanonical PAMs having CRISPR-interference abilities similar to the canonical PAMs; (ii) PAM positioning appears precise, with no evidence for tolerance to PAM slippage in interference; and (iii) while increased guanine-cytosine (GC) content in the spacer is associated with higher CRISPR-interference efficiency, high GC content (>62.5%) decreases CRISPR-interference efficiency. Our findings provide a comprehensive functional profile of Cascade type I-E interference requirements and a method to assay spacer efficacy that can be applied to other CRISPR-Cas systems.
Copyright © 2017 by the Genetics Society of America.

Entities:  

Keywords:  CRISPR-Cas; CRISPR-interference; Cascade; guide efficacy; phage

Mesh:

Substances:

Year:  2017        PMID: 28634160      PMCID: PMC5560783          DOI: 10.1534/genetics.117.202580

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  58 in total

1.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.

Authors:  Xuebing Wu; David A Scott; Andrea J Kriz; Anthony C Chiu; Patrick D Hsu; Daniel B Dadon; Albert W Cheng; Alexandro E Trevino; Silvana Konermann; Sidi Chen; Rudolf Jaenisch; Feng Zhang; Phillip A Sharp
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

2.  Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system.

Authors:  Ki Hyun Nam; Charles Haitjema; Xueqi Liu; Fran Ding; Hongwei Wang; Matthew P DeLisa; Ailong Ke
Journal:  Structure       Date:  2012-07-26       Impact factor: 5.006

3.  Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems.

Authors:  Sergey Shmakov; Omar O Abudayyeh; Kira S Makarova; Yuri I Wolf; Jonathan S Gootenberg; Ekaterina Semenova; Leonid Minakhin; Julia Joung; Silvana Konermann; Konstantin Severinov; Feng Zhang; Eugene V Koonin
Journal:  Mol Cell       Date:  2015-10-22       Impact factor: 17.970

4.  Phage response to CRISPR-encoded resistance in Streptococcus thermophilus.

Authors:  Hélène Deveau; Rodolphe Barrangou; Josiane E Garneau; Jessica Labonté; Christophe Fremaux; Patrick Boyaval; Dennis A Romero; Philippe Horvath; Sylvain Moineau
Journal:  J Bacteriol       Date:  2007-12-07       Impact factor: 3.490

5.  In vitro reconstitution of an Escherichia coli RNA-guided immune system reveals unidirectional, ATP-dependent degradation of DNA target.

Authors:  Sabin Mulepati; Scott Bailey
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

6.  Sequence- and structure-specific RNA processing by a CRISPR endonuclease.

Authors:  Rachel E Haurwitz; Martin Jinek; Blake Wiedenheft; Kaihong Zhou; Jennifer A Doudna
Journal:  Science       Date:  2010-09-10       Impact factor: 47.728

7.  Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system.

Authors:  Ruth Kiro; Dror Shitrit; Udi Qimron
Journal:  RNA Biol       Date:  2014-01-22       Impact factor: 4.652

Review 8.  Regulation of transcription elongation and termination.

Authors:  Robert S Washburn; Max E Gottesman
Journal:  Biomolecules       Date:  2015-05-29

9.  Easy regulation of metabolic flux in Escherichia coli using an endogenous type I-E CRISPR-Cas system.

Authors:  Yizhao Chang; Tianyuan Su; Qingsheng Qi; Quanfeng Liang
Journal:  Microb Cell Fact       Date:  2016-11-15       Impact factor: 5.328

10.  Rapid characterization of CRISPR-Cas9 protospacer adjacent motif sequence elements.

Authors:  Tautvydas Karvelis; Giedrius Gasiunas; Joshua Young; Greta Bigelyte; Arunas Silanskas; Mark Cigan; Virginijus Siksnys
Journal:  Genome Biol       Date:  2015-11-19       Impact factor: 13.583

View more
  7 in total

Review 1.  Mechanisms of Type I-E and I-F CRISPR-Cas Systems in Enterobacteriaceae.

Authors:  Chaoyou Xue; Dipali G Sashital
Journal:  EcoSal Plus       Date:  2019-02

2.  Viral recombination systems limit CRISPR-Cas targeting through the generation of escape mutations.

Authors:  Amer A Hossain; Jon McGinn; Alexander J Meeske; Joshua W Modell; Luciano A Marraffini
Journal:  Cell Host Microbe       Date:  2021-09-27       Impact factor: 31.316

3.  Systematic analysis of Type I-E Escherichia coli CRISPR-Cas PAM sequences ability to promote interference and primed adaptation.

Authors:  Olga Musharova; Vasily Sitnik; Marnix Vlot; Ekaterina Savitskaya; Kirill A Datsenko; Andrey Krivoy; Ivan Fedorov; Ekaterina Semenova; Stan J J Brouns; Konstantin Severinov
Journal:  Mol Microbiol       Date:  2019-04-06       Impact factor: 3.501

4.  CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.

Authors:  Hiroyuki Morisaka; Kazuto Yoshimi; Yuya Okuzaki; Peter Gee; Yayoi Kunihiro; Ekasit Sonpho; Huaigeng Xu; Noriko Sasakawa; Yuki Naito; Shinichiro Nakada; Takashi Yamamoto; Shigetoshi Sano; Akitsu Hotta; Junji Takeda; Tomoji Mashimo
Journal:  Nat Commun       Date:  2019-12-06       Impact factor: 14.919

5.  Prophage Diversity Across Salmonella and Verotoxin-Producing Escherichia coli in Agricultural Niches of British Columbia, Canada.

Authors:  Karen Fong; Yu Tong Lu; Thomas Brenner; Justin Falardeau; Siyun Wang
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

6.  Dynamic mechanisms of CRISPR interference by Escherichia coli CRISPR-Cas3.

Authors:  Kazuto Yoshimi; Kohei Takeshita; Noriyuki Kodera; Satomi Shibumura; Yuko Yamauchi; Mine Omatsu; Kenichi Umeda; Yayoi Kunihiro; Masaki Yamamoto; Tomoji Mashimo
Journal:  Nat Commun       Date:  2022-08-30       Impact factor: 17.694

7.  The type I-E CRISPR-Cas system influences the acquisition of blaKPC-IncF plasmid in Klebsiella pneumonia.

Authors:  Ying Zhou; Yu Tang; Pan Fu; Dongxing Tian; Lianhua Yu; Yunkun Huang; Gang Li; Meng Li; Yong Wang; Zehua Yang; Xiaogang Xu; Zhe Yin; Dongsheng Zhou; Laurent Poirel; Xiaofei Jiang
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.